Global and China PARP Inhibitor Biomarkers Service Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: GCBDED58360EEN
QYResearch

Abstracts

Global PARP Inhibitor Biomarkers Service Scope and Market Size
PARP Inhibitor Biomarkers Service market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PARP Inhibitor Biomarkers Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• BRCA 1 & 2 Testing
• HRD Testing
• HRR Testing
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Others

Based on regional and country-level analysis, the PARP Inhibitor Biomarkers Service market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global PARP Inhibitor Biomarkers Service market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Myriad Genetics, Inc.
• Hoffmann-La Roche AG
• Invitae Corporation
• NeoGenomics Laboratories, Inc.
• BPS Bioscience, Inc.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 BRCA 1 & 2 Testing
  1.2.3 HRD Testing
  1.2.4 HRR Testing
  1.2.5 Others
1.3 Market by Application
  1.3.1 Global PARP Inhibitor Biomarkers Service Market Share by Application: 2020 VS 2026
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global PARP Inhibitor Biomarkers Service Market Perspective (2015-2026)
2.2 Global PARP Inhibitor Biomarkers Service Growth Trends by Regions
  2.2.1 PARP Inhibitor Biomarkers Service Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 PARP Inhibitor Biomarkers Service Historic Market Share by Regions (2015-2020)
  2.2.3 PARP Inhibitor Biomarkers Service Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top PARP Inhibitor Biomarkers Service Players by Market Size
  3.1.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue (2015-2020)
  3.1.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Players (2015-2020)
3.2 Global PARP Inhibitor Biomarkers Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PARP Inhibitor Biomarkers Service Revenue
3.4 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio
  3.4.1 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Service Revenue in 2019
3.5 Key Players PARP Inhibitor Biomarkers Service Area Served
3.6 Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
3.7 Date of Enter into PARP Inhibitor Biomarkers Service Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PARP INHIBITOR BIOMARKERS SERVICE BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Type (2015-2020)
4.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2021-2026)

5 PARP INHIBITOR BIOMARKERS SERVICE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Application (2015-2020)
5.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America PARP Inhibitor Biomarkers Service Market Size (2015-2026)
6.2 North America PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
6.3 North America PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
6.4 North America PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe PARP Inhibitor Biomarkers Service Market Size (2015-2026)
7.2 Europe PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
7.3 Europe PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
7.4 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China PARP Inhibitor Biomarkers Service Market Size (2015-2026)
8.2 China PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
8.3 China PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
8.4 China PARP Inhibitor Biomarkers Service Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan PARP Inhibitor Biomarkers Service Market Size (2015-2026)
9.2 Japan PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
9.3 Japan PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
9.4 Japan PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia PARP Inhibitor Biomarkers Service Market Size (2015-2026)
10.2 Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
10.3 Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
10.4 Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 Myriad Genetics, Inc.
  11.1.1 Myriad Genetics, Inc. Company Details
  11.1.2 Myriad Genetics, Inc. Business Overview
  11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Introduction
  11.1.4 Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020))
  11.1.5 Myriad Genetics, Inc. Recent Development
11.2 Hoffmann-La Roche AG
  11.2.1 Hoffmann-La Roche AG Company Details
  11.2.2 Hoffmann-La Roche AG Business Overview
  11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Introduction
  11.2.4 Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  11.2.5 Hoffmann-La Roche AG Recent Development
11.3 Invitae Corporation
  11.3.1 Invitae Corporation Company Details
  11.3.2 Invitae Corporation Business Overview
  11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Introduction
  11.3.4 Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  11.3.5 Invitae Corporation Recent Development
11.4 NeoGenomics Laboratories, Inc.
  11.4.1 NeoGenomics Laboratories, Inc. Company Details
  11.4.2 NeoGenomics Laboratories, Inc. Business Overview
  11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Introduction
  11.4.4 NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  11.4.5 NeoGenomics Laboratories, Inc. Recent Development
11.5 BPS Bioscience, Inc.
  11.5.1 BPS Bioscience, Inc. Company Details
  11.5.2 BPS Bioscience, Inc. Business Overview
  11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Introduction
  11.5.4 BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  11.5.5 BPS Bioscience, Inc. Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of BRCA 1 & 2 Testing
Table 4. Key Players of HRD Testing
Table 5. Key Players of HRR Testing
Table 6. Key Players of Others
Table 7. Global PARP Inhibitor Biomarkers Service Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global PARP Inhibitor Biomarkers Service Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global PARP Inhibitor Biomarkers Service Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global PARP Inhibitor Biomarkers Service Market Share by Regions (2015-2020)
Table 11. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global PARP Inhibitor Biomarkers Service Market Share by Regions (2021-2026)
Table 13. PARP Inhibitor Biomarkers Service Market Market Trends
Table 14. PARP Inhibitor Biomarkers Service Market Drivers
Table 15. PARP Inhibitor Biomarkers Service Market Challenges
Table 16. PARP Inhibitor Biomarkers Service Market Restraints
Table 17. Global PARP Inhibitor Biomarkers Service Revenue by Players (2015-2020) (US$ Million)
Table 18. Global PARP Inhibitor Biomarkers Service Market Share by Players (2015-2020)
Table 19. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2019)
Table 20. Global PARP Inhibitor Biomarkers Service by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020) (US$ Million)
Table 25. Global PARP Inhibitor Biomarkers Service Market Size Share by Type (2015-2020)
Table 26. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2021-2026)
Table 27. Global PARP Inhibitor Biomarkers Service Market Size Share by Application (2015-2020)
Table 28. Global PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020) (US$ Million)
Table 29. Global PARP Inhibitor Biomarkers Service Market Size Share by Application (2021-2026)
Table 30. North America PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020) (US$ Million)
Table 31. North America PARP Inhibitor Biomarkers Service Market Share by Type (2015-2020)
Table 32. North America PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020) (US$ Million)
Table 33. North America PARP Inhibitor Biomarkers Service Market Share by Application (2015-2020)
Table 34. North America PARP Inhibitor Biomarkers Service Market Size by Country (US$ Million) (2015-2020)
Table 35. North America PARP Inhibitor Biomarkers Service Market Share by Country (2015-2020)
Table 36. Europe PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe PARP Inhibitor Biomarkers Service Market Share by Type (2015-2020)
Table 38. Europe PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe PARP Inhibitor Biomarkers Service Market Share by Application (2015-2020)
Table 40. Europe PARP Inhibitor Biomarkers Service Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe PARP Inhibitor Biomarkers Service Market Share by Country (2015-2020)
Table 42. China PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020) (US$ Million)
Table 43. China PARP Inhibitor Biomarkers Service Market Share by Type (2015-2020)
Table 44. China PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020) (US$ Million)
Table 45. China PARP Inhibitor Biomarkers Service Market Share by Application (2015-2020)
Table 46. China PARP Inhibitor Biomarkers Service Market Size by Region (US$ Million) (2015-2020)
Table 47. China PARP Inhibitor Biomarkers Service Market Share by Region (2015-2020)
Table 48. Japan PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan PARP Inhibitor Biomarkers Service Market Share by Type (2015-2020)
Table 50. Japan PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan PARP Inhibitor Biomarkers Service Market Share by Application (2015-2020)
Table 52. Japan PARP Inhibitor Biomarkers Service Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan PARP Inhibitor Biomarkers Service Market Share by Country (2015-2020)
Table 54. Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia PARP Inhibitor Biomarkers Service Market Share by Type (2015-2020)
Table 56. Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia PARP Inhibitor Biomarkers Service Market Share by Application (2015-2020)
Table 58. Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia PARP Inhibitor Biomarkers Service Market Share by Country (2015-2020)
Table 60. Myriad Genetics, Inc. Company Details
Table 61. Myriad Genetics, Inc. Business Overview
Table 62. Myriad Genetics, Inc. Product
Table 63. Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020) (US$ Million)
Table 64. Myriad Genetics, Inc. Recent Development
Table 65. Hoffmann-La Roche AG Company Details
Table 66. Hoffmann-La Roche AG Business Overview
Table 67. Hoffmann-La Roche AG Product
Table 68. Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020) (US$ Million)
Table 69. Hoffmann-La Roche AG Recent Development
Table 70. Invitae Corporation Company Details
Table 71. Invitae Corporation Business Overview
Table 72. Invitae Corporation Product
Table 73. Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020) (US$ Million)
Table 74. Invitae Corporation Recent Development
Table 75. NeoGenomics Laboratories, Inc. Company Details
Table 76. NeoGenomics Laboratories, Inc. Business Overview
Table 77. NeoGenomics Laboratories, Inc. Product
Table 78. NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020) (US$ Million)
Table 79. NeoGenomics Laboratories, Inc. Recent Development
Table 80. BPS Bioscience, Inc. Company Details
Table 81. BPS Bioscience, Inc. Business Overview
Table 82. BPS Bioscience, Inc. Product
Table 83. BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020) (US$ Million)
Table 84. BPS Bioscience, Inc. Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global PARP Inhibitor Biomarkers Service Market Share by Type: 2020 VS 2026
Figure 2. BRCA 1 & 2 Testing Features
Figure 3. HRD Testing Features
Figure 4. HRR Testing Features
Figure 5. Others Features
Figure 6. Global PARP Inhibitor Biomarkers Service Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. PARP Inhibitor Biomarkers Service Report Years Considered
Figure 11. Global PARP Inhibitor Biomarkers Service Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global PARP Inhibitor Biomarkers Service Market Share by Regions: 2020 VS 2026
Figure 13. Global PARP Inhibitor Biomarkers Service Market Share by Regions (2021-2026)
Figure 14. Global PARP Inhibitor Biomarkers Service Market Share by Players in 2019
Figure 15. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2019
Figure 16. The Top 10 and 5 Players Market Share by PARP Inhibitor Biomarkers Service Revenue in 2019
Figure 17. North America PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa PARP Inhibitor Biomarkers Service Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Myriad Genetics, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2015-2020)
Figure 45. Hoffmann-La Roche AG Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2015-2020)
Figure 46. Invitae Corporation Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2015-2020)
Figure 47. NeoGenomics Laboratories, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2015-2020)
Figure 48. BPS Bioscience, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed